Page last updated: 2024-10-29

staurosporine aglycone and Stroke

staurosporine aglycone has been researched along with Stroke in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qi, D1
Ouyang, C1
Wang, Y1
Zhang, S1
Ma, X1
Song, Y1
Yu, H1
Tang, J1
Fu, W1
Sheng, L1
Yang, L1
Wang, M1
Zhang, W1
Miao, L1
Li, T1
Huang, X1
Dong, H1

Other Studies

1 other study available for staurosporine aglycone and Stroke

ArticleYear
HO-1 attenuates hippocampal neurons injury via the activation of BDNF-TrkB-PI3K/Akt signaling pathway in stroke.
    Brain research, 2014, Aug-19, Volume: 1577

    Topics: Animals; Apoptosis; Brain Ischemia; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; Carb

2014